|
US6730507B1
(en)
|
1993-06-24 |
2004-05-04 |
Merck & Co., Inc. |
Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
|
|
US6756226B2
(en)
*
|
1994-05-31 |
2004-06-29 |
Frank L. Graham |
Enhanced system for construction of adenovirus vectors
|
|
US6379943B1
(en)
*
|
1999-03-05 |
2002-04-30 |
Merck & Co., Inc. |
High-efficiency Cre/loxp based system for construction of adenovirus vectors
|
|
US6964861B1
(en)
|
1998-11-13 |
2005-11-15 |
Invitrogen Corporation |
Enhanced in vitro recombinational cloning of using ribosomal proteins
|
|
US6720140B1
(en)
|
1995-06-07 |
2004-04-13 |
Invitrogen Corporation |
Recombinational cloning using engineered recombination sites
|
|
US6974694B2
(en)
|
1995-06-07 |
2005-12-13 |
Advec, Inc. |
Adenoviruses for control of gene expression
|
|
PT937098E
(pt)
|
1995-06-07 |
2002-12-31 |
Invitrogen Corp |
Clonagem recombinatoria in vitro utilizando locais de recombinacao modificados
|
|
US6143557A
(en)
|
1995-06-07 |
2000-11-07 |
Life Technologies, Inc. |
Recombination cloning using engineered recombination sites
|
|
FR2749857B1
(fr)
*
|
1996-06-12 |
1998-08-14 |
Centre Nat Rech Scient |
Generation de molecules replicatives in vivo
|
|
CA2272121A1
(en)
*
|
1996-11-19 |
1998-05-28 |
Uab Research Foundation |
Chimeric retrovirus/adenovirus system
|
|
US6403370B1
(en)
*
|
1997-02-10 |
2002-06-11 |
Genstar Therapeutics Corporation |
Oncolytic/immunogenic complementary-adenoviral vector system
|
|
US7030096B1
(en)
*
|
1997-02-13 |
2006-04-18 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein
|
|
US5851808A
(en)
|
1997-02-28 |
1998-12-22 |
Baylor College Of Medicine |
Rapid subcloning using site-specific recombination
|
|
IL131979A0
(en)
|
1997-03-21 |
2001-03-19 |
Enzo Therapeutics Inc |
Vectors and viral vectors and packaging cell lines for propagating the same
|
|
WO1998046778A1
(en)
*
|
1997-04-11 |
1998-10-22 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Transgenomic viruses and the use thereof
|
|
CA2304173A1
(en)
|
1997-09-23 |
1999-04-01 |
Genvec, Inc. |
Plasmids for construction of eukaryotic viral vectors
|
|
CA2307016A1
(en)
*
|
1997-10-24 |
1999-05-06 |
Life Technologies, Inc. |
Recombinational cloning using nucleic acids having recombination sites
|
|
US7351578B2
(en)
|
1999-12-10 |
2008-04-01 |
Invitrogen Corp. |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
|
DE19807265C2
(de)
*
|
1998-02-20 |
2000-01-05 |
Centeon Pharma Gmbh |
Adenoviraler Transfervektor für den Gentransport einer DNA-Sequenz
|
|
US6413776B1
(en)
*
|
1998-06-12 |
2002-07-02 |
Galapagos Geonomics N.V. |
High throughput screening of gene function using adenoviral libraries for functional genomics applications
|
|
US6576463B1
(en)
|
1999-01-15 |
2003-06-10 |
The Regents Of The University Of California |
Hybrid vectors for gene therapy
|
|
EP2336148A1
(en)
|
1999-03-02 |
2011-06-22 |
Life Technologies Corporation |
Compositions and methods for use in recombinational cloning of nucleic acids
|
|
WO2000052187A2
(en)
*
|
1999-03-05 |
2000-09-08 |
Merck & Co., Inc. |
Enhanced system for construction of adenovirus vectors
|
|
EP2210948A3
(en)
*
|
1999-12-10 |
2010-10-06 |
Life Technologies Corporation |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
|
US7052904B2
(en)
|
2000-01-31 |
2006-05-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Hybrid adeno-retroviral vector for the transfection of cells
|
|
US7244560B2
(en)
|
2000-05-21 |
2007-07-17 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
|
EP2336339A3
(en)
|
2000-09-25 |
2011-09-14 |
The Regents of the University of Michigan |
Production of viral vectors
|
|
US7723102B2
(en)
*
|
2000-09-28 |
2010-05-25 |
Bayer Corporation |
Enhanced transfection system
|
|
US7226779B2
(en)
|
2001-01-30 |
2007-06-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Hybrid adenoviral vector
|
|
US6943012B2
(en)
*
|
2001-03-26 |
2005-09-13 |
The Board Of Trustees Of The Leland Stanford Junor University |
Helper dependent adenoviral vector system and methods for using the same
|
|
WO2002085287A2
(en)
*
|
2001-04-18 |
2002-10-31 |
Genstar Therapeutics Corp. |
Minimal adenoviral vectors for immunization
|
|
WO2003062400A2
(en)
*
|
2002-01-24 |
2003-07-31 |
The Scripps Research Institute |
Fiber shaft modifications for efficient targeting
|
|
US8304233B2
(en)
|
2002-06-04 |
2012-11-06 |
Poetic Genetics, Llc |
Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
|
|
US20040203133A1
(en)
*
|
2003-01-07 |
2004-10-14 |
Anja Ehrhardt |
Helper dependent adenoviral vector system and methods for using the same
|
|
US20050042217A1
(en)
*
|
2003-03-19 |
2005-02-24 |
Yan Qi |
Specific inhibition of allorejection
|
|
CA2519680A1
(en)
|
2003-03-28 |
2004-11-18 |
The Scripps Research Institute |
Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
|
|
US8304189B2
(en)
|
2003-12-01 |
2012-11-06 |
Life Technologies Corporation |
Nucleic acid molecules containing recombination sites and methods of using the same
|
|
JP2008507282A
(ja)
|
2004-07-20 |
2008-03-13 |
アイソジェニス・インコーポレイテッド |
自己免疫および自己抗原に関連する疾患の特異的阻害
|
|
WO2006031689A2
(en)
|
2004-09-13 |
2006-03-23 |
Genzyme Corporation |
Multimeric constructs
|
|
AR059089A1
(es)
|
2006-01-20 |
2008-03-12 |
Genzyme Corp |
Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
|
|
WO2007095056A2
(en)
|
2006-02-09 |
2007-08-23 |
Genzyme Corporation |
Slow intraventricular delivery
|
|
EP2342321B1
(en)
|
2008-09-17 |
2018-04-11 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
US20230172175A1
(en)
|
2020-03-15 |
2023-06-08 |
Proteinea, Inc. |
Recombinant protein production in insects
|